Clinical Trial Update: Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A Phase II study of temozolomide for newly diagnosed glioblastoma and gliosarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: TERMINATED